Dr. Michael A. Rosenzweig
Claim this profileCity of Hope Medical Center
Studies Multiple Myeloma
Studies Amyloidosis
4 reported clinical trials
6 drugs studied
Area of expertise
1Multiple Myeloma
2Amyloidosis
t(11;14) positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Michael A. Rosenzweig is currently running
Triple Drug Therapy
for Multiple Myeloma
This phase II trial studies how well leflunomide, pomalidomide, and dexamethasone work for the treatment of multiple myeloma that has come back (relapsed) or does not respond to treatment (refractory). Leflunomide may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with pomalidomide, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving leflunomide with pomalidomide and dexamethasone may work better in treating multiple myeloma compared to pomalidomide and dexamethasone alone.
Recruiting1 award Phase 224 criteria
Leflunomide
for High-Risk Smoldering Multiple Myeloma
This phase II trial studies the effects of leflunomide in treating African-American and European-American patients with high-risk smoldering multiple myeloma. Leflunomide is used to decrease the body's immune response and may delay the symptoms of multiple myeloma in patients of African-American and European decent.
Recruiting1 award Phase 223 criteria
More about Michael A. Rosenzweig
Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michael A. Rosenzweig has experience with
- Dexamethasone
- Leflunomide
- Pomalidomide
- Ixazomib Citrate
- Venetoclax
- STI-6129
Breakdown of trials Michael A. Rosenzweig has run
Multiple Myeloma
AL Amyloidosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael A. Rosenzweig specialize in?
Michael A. Rosenzweig focuses on Multiple Myeloma and Amyloidosis. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Michael A. Rosenzweig currently recruiting for clinical trials?
Yes, Michael A. Rosenzweig is currently recruiting for 2 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Michael A. Rosenzweig has studied deeply?
Yes, Michael A. Rosenzweig has studied treatments such as Dexamethasone, Leflunomide, Pomalidomide.
What is the best way to schedule an appointment with Michael A. Rosenzweig?
Apply for one of the trials that Michael A. Rosenzweig is conducting.
What is the office address of Michael A. Rosenzweig?
The office of Michael A. Rosenzweig is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.